Industry Segment Information (Tables)

9 Months Ended

Oct. 03, 2021

Segment Reporting [Abstract]

Schedule of Sales and Operating Income by Operating Segment, Excluding Discontinued Operations

Revenue and operating income (loss) from continuing operations by operating segment are shown in the table below: 

	Three Months Ended				Nine Months Ended
	October 3, 2021		October 4, 2020		October 3, 2021		October 4, 2020
	(In thousands)
Discovery & Analytical Solutions
Product revenue	$	318,456	$	245,556	$	903,796	$	686,529
Service revenue	194,423		178,067		576,521		526,491
Total revenue	512,879		423,623		1,480,317		1,213,020
Operating income from continuing operations	7,146		42,689		114,248		110,632
Diagnostics
Product revenue	467,413		491,290		1,461,384		1,077,352
Service revenue	186,392		49,112		761,143		137,767
Total revenue	653,805		540,402		2,222,527		1,215,119
Operating income from continuing operations	237,903		223,819		965,650		413,710
Corporate
Operating loss from continuing operations	(23,079)		(18,502)		(57,664)		(56,015)
Continuing Operations
Product revenue	785,869		736,846		2,365,180		1,763,881
Service revenue	380,815		227,179		1,337,664		664,258
Total revenue	1,166,684		964,025		3,702,844		2,428,139
Operating income from continuing operations	221,970		248,006		1,022,234		468,327
Interest and other expense, net (see Note 5)	60,302		14,249		54,027		35,054
Income from continuing operations before income taxes	$	161,668	$	233,757	$	968,207	$	433,273